Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.

Revenue
+1.42%
EPS
+17.9%
Free cash flow
+29.0%
Total debt
−3.65%

Quarter to September 2026, against a year earlier

425.62 6.38 −1.48%
Market cap
$93.3B
P/E
18.2×
Fwd P/E
19.0×
Dividend yield
1.61%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
6 6 6 6

+8 more TTM periods

ROE
11.56% 11.17% 12.10% 13.25%
ROA
4.10% 4.00% 4.27% 4.75%
ROIC
12.76% 11.83% 12.52% 12.74%
Return on Tangible Assets
19.41% 18.00% 19.87% 21.25%
Average Days of Receivables
44.44 42.45 41.51 39.49
Free Cash Flow per Share
30.07 28.98 29.34 14.17
Free Cash Flow
6,514.00 6,289.00 6,450.00 3,174.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026